Zobrazeno 71 - 80
of 17 952
pro vyhledávání: ''
Autor:
Takahiko Nakamura, Kenjiro Tsuruoka, Kiyoe Kanaoka, Yosuke Tamura, Yasuhito Fujisaka, Soichiro Ikeda, Tomoya Funamoto, Masafumi Imanishi, Isao Goto, Akihisa Imagawa, Hiroyuki Tsuji, Sho Mitsuya, Ninso Matsunaga
Publikováno v:
Anticancer Research. 41:5137-5145
BACKGROUND For epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), administration of EGFR tyrosine kinase inhibitors (TKIs) is mandatory to prolong survival. To date, a comparison of second- and third-generation EGFR-T
Autor:
Asami Yagi, Tomio Nakayama, Yutaka Ueda, Kosuke Hiramatsu, Eiji Kobayashi, Ai Miyoshi, Toshitaka Morishima, Yuri Ito, Satoshi Nakagawa, Isao Miyashiro, Tadashi Kimura, Kayo Nakata, Toshihiro Kimura, Sayaka Ikeda
Publikováno v:
International Journal of Cancer. 150:232-242
The incidence of uterine corpus cancer has been increasing globally due to increase in obesity. However, a detailed analysis of long-term epidemiological trends of corpus cancer in Japan, where obesity is relatively minimal, has not been conducted. I
Autor:
Yoichi Nakanishi, Yuichiro Ohe, Akihiko Gemma, Kazuhiko Nakagawa, Ayumi Akamatsu, Takahiko Sakamoto, Nobuyuki Yamamoto
Publikováno v:
Cancer Science
Postmarketing surveillance of Japanese patients with unresectable, previously treated, advanced or recurrent non‐small‐cell lung cancer treated with nivolumab was undertaken during the conditional approval period. The study aim was to evaluate th
Publikováno v:
Hematological Oncology. 39:674-679
The purpose of our study is to highlight the demographic characteristics, pathological features, and clinical course of multiple myeloma (MM) patients with secondary primary malignancies (SPM). A retrospective chart review was performed from January
Autor:
Nicole Rademacher, Tina W.F. Yen, Kirsten M. M. Beyer, Sara Beltrán Ponce, Purushottam W. Laud, Emily L. McGinley, Ann B. Nattinger, Sima Namin, Jamila L. Kwarteng, Courtney Jankowski, Yuhong Zhou
Publikováno v:
Journal of Clinical Oncology. 39:2749-2757
PURPOSE The objective was to examine the relationship between contemporary redlining (mortgage lending bias on the basis of property location) and survival among older women with breast cancer in the United States. METHODS A redlining index using Hom
Autor:
Hideo Baba, Yusuke Taniyama, Naoya Yoshida, Kozue Takahashi, Kentaro Murakami, Takashi Kamei, Hisahiro Matsubara
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background Evaluating the effect on primary lesions is important in determining treatment strategies for esophageal cancer. The Response Evaluation Criteria in Solid Tumors system, which employs the longest diameter for measuring tumors, is commonly
Publikováno v:
Anticancer Research. 41:4529-4534
BACKGROUND/AIM Blood transfusion and a large amount of intraoperative blood loss (IBL) have been reported to have a negative impact on long-term survival via immunosuppression. In recent years, thanks to the spread of laparoscopic surgery and the dev
Autor:
Koichi Takahashi, Nitin Jain, Guillermo Garcia-Manero, Lucia Masarova, Sa Wang, Courtney D. DiNardo, Naveen Pemmaraju, Guillermo Montalban Bravo, Tapan M. Kadia, Sanam Loghavi, Musa Yilmaz, Ghayas C. Issa, Koji Sasaki, Elias Jabbour, Steven M. Kornblau, Abhishek Maiti, Marina Konopleva, Lianchun Xiao, Curtis Lachowiez, Maria Adeoti, Farhad Ravandi, Michael Andreeff, Nicholas J. Short, Gautam Borthakur, Hagop M. Kantarjian, Naval Daver, Yesid Alvarado
Publikováno v:
J Clin Oncol
PURPOSE Sixty percent of newly diagnosed patients with acute myeloid leukemia (ND-AML) receiving frontline therapy attain a complete response (CR), yet 30%-40% of patients relapse. Relapsed or refractory AML (R/R-AML) remains a particularly adverse p
Autor:
Dunia de Miguel, Dorothy Romanus, Shelby Corman, Courtney Johnson, Ernesto Pérez Persona, Marta Grande, Katharina Verleger, Dasha Cherepanov, Jose Angel Hernandez-Rivas, José Maria Arguiñano Pérez, Mario Arnao, Araceli Rubio, Esther González Garcia
Publikováno v:
FUTURE ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Lay abstract This study describes treatment patterns and outcomes in newly diagnosed multiple myeloma (NDMM) patients in Spain who were not candidates for transplant. The study looked at two patient groups: patients diagnosed between 1 January 2012 a
Autor:
Wataru Obara, Sei Naito, Yumin Muto, Takahiro Kojima, Chikara Ohyama, Yoshihide Kawasaki, Shingo Hatakeyama, Akihiro Ito, Syuya Kandori, Hiroyuki Nishiyama, Norihiko Tsuchiya, Sadafumi Kawamura, Tomonori Habuchi, Tomoyuki Koguchi, Yoshiyuki Kojima, Renpei Kato, Kazuyuki Numakura, Yoichi Arai
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 17, Pp 5839-5846 (2021)
Cancer Medicine, Vol 10, Iss 17, Pp 5839-5846 (2021)
Although combination immune checkpoint inhibitor (immuno‐oncology [IO]) therapy is the first‐line treatment for metastatic renal cell carcinoma (mRCC), it mostly causes resistance and tumor regrowth. Therefore, an optimal second‐line therapy is